From Wall Street trading floors to the Federal Reserve to economists sipping coffee in their home offices, the first Friday morning of the month typically brings a quiet hush around 8:30 a.m. eastern,...

Wall Street is retreating from its record as a slide for Walmart weighs on U.S. stock indexes. The S&P 500 fell 0.9% Thursday after setting all-time highs in each of the last two days.

Shares are higher in Europe and Asia though U.S. futures have fallen after U.S. President Donald Trump vowed to press ahead with more tariffs hikes despite worries over the economy and markets.

European shares have opened lower after a day of gains in Asia as investors watch for the next steps in President Donald Trump’s trade war.

U.S. stocks are swerving through another shaky day of trading, with uncertainty still high about just what President Donald Trump will announce about tariffs on his “Liberation Day.”

European markets open lower while Asian stocks are mixed after U.S. indexes declined ahead of an update on consumer inflation due later Wednesday.

Stocks are falling in afternoon trading but the losses softened enough to give Wall Street a chance to snap a weekly losing streak. The S&P 500 was down 0.2% Friday.

U.S. stocks are drifting in mixed trading as Wall Street’s momentum slows after setting records in each of the last two days.

U.S. stocks are drifting around their records in a quiet start to trading on Wall Street. The S&P 500 rose 0.1% Tuesday, coming off its latest all-time high and a seven-day winning streak.

Bitcoin's transformative impact reverberates across Asia as Hong Kong emerges as a crypto hub. Today, six spot bitcoin and ether exchange-traded funds (ETFs)

Changes to board representation and listing rules are aimed at making Hong Kong a more attractive listing destination, HKEX says.

GUANGZHOU, China, January 17, 2025 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceuticals (TADAWUL:) Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4. FZ002-037 is a highly selective oral small molecule SSTR4 agonist developed by Fermion. Preclinical studies indicate that the drug provides primarily peripheral analgesia without central side effects or addiction risks, making it a promising option for patients requiring long-term pain management.

BEIJING, March 13, 2025 /PRNewswire/ — Weibo Corporation (“Weibo” or the “Company”) (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31,…

Global shares have slumped, with benchmarks in Tokyo and Taiwan falling more than 4% after Wall Street had another wipeout.

Ping An of China Asset Management (HK) is set to join the HKEX Integrated Fund Platform, enhancing fund distribution efficiency and client access.

Asian shares are mostly higher after a bumpy ride on Wall Street. Markets advanced in Tokyo, Taiwan and Seoul in thin Good Friday trading.

Yum China Holdings announces its board might declare a quarterly dividend by April 30, 2025, pending decisions made by directors, in compliance with HKEX regulations.

This LawFlash breaks down the key conclusions of the HKEx’s consultation on optimizing IPO price discovery and open market requirements, which...